134 related articles for article (PubMed ID: 32802732)
1. Association of JMJD2B and Hypoxia-Inducible Factor 1 Expressions with Poor Prognosis in Osteosarcoma.
Liu X; Zhang Q; Zhao Y; Xun J; Wu H; Feng H
Anal Cell Pathol (Amst); 2020; 2020():2563208. PubMed ID: 32802732
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.
Zhao H; Wu Y; Chen Y; Liu H
Int J Clin Oncol; 2015 Dec; 20(6):1233-43. PubMed ID: 26077139
[TBL] [Abstract][Full Text] [Related]
3. Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma.
Li X; Dong S
Med Oncol; 2015 Mar; 32(3):53. PubMed ID: 25636512
[TBL] [Abstract][Full Text] [Related]
4. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
[TBL] [Abstract][Full Text] [Related]
5. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma.
Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q
Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210
[TBL] [Abstract][Full Text] [Related]
6. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.
Beyer S; Kristensen MM; Jensen KS; Johansen JV; Staller P
J Biol Chem; 2008 Dec; 283(52):36542-52. PubMed ID: 18984585
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung Adenocarcinoma.
Toyokawa G; Taguchi K; Edagawa M; Shimamatsu S; Toyozawa R; Nosaki K; Hirai F; Yamaguchi M; Shimokawa M; Seto T; Takenoyama M; Hamamoto R; Sugio K; Ichinose Y
Anticancer Res; 2016 Sep; 36(9):4841-6. PubMed ID: 27630338
[TBL] [Abstract][Full Text] [Related]
8. SDF-1 Expression is Associated with Poor Prognosis in Osteosarcoma.
Yu D; Lv F; Zhang J; Li H
Ann Clin Lab Sci; 2016 Sep; 46(5):508-14. PubMed ID: 27650618
[TBL] [Abstract][Full Text] [Related]
9. BMPR2 and HIF1-
Wang S; Ren T; Huang Y; Bao X; Sun K; Shen D; Guo W
Chin J Cancer Res; 2017 Oct; 29(5):447-454. PubMed ID: 29142464
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].
Diao YQ; Wang J; Zhu XL; Chen J; Zheng Y; Jiang L; Liu YP; Dai RH; Yan YW
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Nov; 25(11):1150-1155. PubMed ID: 37990460
[TBL] [Abstract][Full Text] [Related]
11. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
Zhang B; Pang QJ; Zhang HJ; Yuan Y
Zhongguo Gu Shang; 2011 Dec; 24(12):982-6. PubMed ID: 22276503
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism.
Fu L; Chen L; Yang J; Ye T; Chen Y; Fang J
Carcinogenesis; 2012 Sep; 33(9):1664-73. PubMed ID: 22745382
[TBL] [Abstract][Full Text] [Related]
13. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.
Hu T; He N; Yang Y; Yin C; Sang N; Yang Q
J Exp Clin Cancer Res; 2015 Feb; 34(1):22. PubMed ID: 25884381
[TBL] [Abstract][Full Text] [Related]
14. Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer.
Chen L; Fu L; Kong X; Xu J; Wang Z; Ma X; Akiyama Y; Chen Y; Fang J
Br J Cancer; 2014 Feb; 110(4):1014-26. PubMed ID: 24473398
[TBL] [Abstract][Full Text] [Related]
15. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
16. Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma.
Liu Y; Sun X; Huo C; Sun C; Zhu J
Med Sci Monit; 2019 Jun; 25():4278-4284. PubMed ID: 31177263
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
18. Enterotoxigenic
Liu QQ; Li CM; Fu LN; Wang HL; Tan J; Wang YQ; Sun DF; Gao QY; Chen YX; Fang JY
Gut Microbes; 2020 Nov; 12(1):1788900. PubMed ID: 32684087
[TBL] [Abstract][Full Text] [Related]
19. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
Chen Y; Wang CM; Shi YQ; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
[TBL] [Abstract][Full Text] [Related]
20. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
